Philip Morris International Welcomes Broad Interest for PMI IMPACT; New Global Initiative to Fight Smuggling and Related Crimes Receives over 200 Project Proposals in First Funding Round
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) announced today that the response to PMI IMPACT, its new global funding initiative for third party projects dedicated to fighting smuggling and related crimes, has exceeded expectations with more than 200 expressions of interest submitted in the first funding round. PMI has pledged USD 100 million for three funding rounds.
“We are delighted to see that PMI IMPACT has been well-received and that a broad range of organizations recognized the need to join forces to eliminate illegal trade in its many forms. With the leadership of the Expert Council, PMI IMPACT will provide resources for the best proposals to bring innovative and lasting solutions,” stated Alvise Giustiniani, Vice President Illicit Trade Strategies & Prevention, of PMI.
The Expert Council comprises external independent experts with impeccable credentials in the fields of law, anti-corruption and law enforcement. The experts will evaluate the project proposals that are suitable for funding.
In total, 170 organizations including government agencies, universities and research institutes, NGOs, and private entities have proposed more than 200 projects under three focus areas: research, education and awareness, and action. Submissions come from 42 countries, primarily in Europe and North America.
For its first funding round, PMI IMPACT called for projects that could have an impact on illegal trade and related crimes in the European Union. Organizations based anywhere in the world were invited to apply, as long as they could demonstrate an impact within the EU, including an impact on the illegal tobacco trade.
Expressions of interest will now go through due diligence checks and quality assessment by the Expert Council. Applicants that pass this stage will be invited to submit their full proposals. The selection process will be completed by Q2 2017.
More information on PMI IMPACT is available online at http://www.pmi-impact.com/ .
About Philip Morris International Inc. (“PMI”)
PMI is the world’s leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro , the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of Reduced-Risk Products (“RRPs”). RRPs is the term PMI uses to refer to products with the potential to reduce individual risk and population harm in comparison to smoking cigarettes. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see www.pmi.com and www.pmiscience.com .
Philip Morris International media office
T: +41 (0)58 242 4500
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
BITFLYER23.1.2018 01:03 | pressemeddelelse
bitFlyer Launches in Europe and Becomes the World’s First Bitcoin Exchange to Be Regulated in Japan, the US and Europe
NY-CORSEARCH22.1.2018 22:02 | pressemeddelelse
Corsearch Names Diane Plaut as Global General Counsel and Head of HR
BACARDI-LIMITED22.1.2018 21:30 | pressemeddelelse
Bacardi to Acquire Patrón Tequila
PA-PMI22.1.2018 18:00 | pressemeddelelse
PMI’s Salary Survey Reveals that Project Management Practitioners with the PMP Certification Earn 23% More
ABB22.1.2018 16:43 | pressemeddelelse
ABB and City of Davos Pave the Way to Sustainable Mobility Through E-Vehicle Innovation
FERRING-PHARMACEUTICALS22.1.2018 15:02 | pressemeddelelse
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum